Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia
Shots: Innovent to receive milestones for development and commercialization along with royalties on net sales of the therapy in the licensed territory. Etana is committed to launch Byvasda in Indonesia The collaboration will enable Byvsada to penetrate into a Southeast Asian market and allow Innovent to bolster its presence globally In Jan’2020, Innovent signed an […]